Ontology type: schema:ScholarlyArticle
2018-02-09
AUTHORSKoichi Kamei, Masao Ogura, Mai Sato, Shuichi Ito, Kenji Ishikura
ABSTRACTBackgroundInfusion reaction (IR) is defined as an adverse event within 24 h after monoclonal antibody infusion. In non-Hodgkin lymphoma, IR incidence following rituximab treatment is high (77–80%), but there are no data in complicated nephrotic syndrome.MethodsRecords of rituximab infusions in patients with complicated nephrotic syndrome between February 2006 and December 2014 at the National Center for Child Health and Development were reviewed. Rituximab was administered at doses of 375 mg/m2. The severity of IR was evaluated using the Common Terminology Criteria for Adverse Events ver. 4.0.ResultsFor 309 rituximab infusions in 159 patients (male, 110; median age, 12 years), IR was observed in 165 infusions (53.4%). Respiratory symptoms were most common (66% of all events). Ninety-five percent of the IR was observed within 3 h after rituximab infusion initiation. Sixty-eight percent of the events were classified as grade 1 and others classified as grade 2. Only 18% required medical intervention. CD20 cell count in patients with IR was significantly higher than in patients without IR. Incidence of IR was similar in subsequent rituximab treatment after B-cell recovery. Patients who experienced IR at first rituximab treatment were more likely to experience recurrent IR with subsequent treatments compared to those not having IR at initial treatment (odds ratio 3.64; p < 0.001).ConclusionsIn patients with complicated nephrotic syndrome, respiratory symptoms were the major type of IR, mostly observed within 3 h of infusion. Incidence of IR was lower and its severity milder in patients with complicated nephrotic syndrome than those with lymphoma. More... »
PAGES1013-1018
http://scigraph.springernature.com/pub.10.1007/s00467-018-3900-z
DOIhttp://dx.doi.org/10.1007/s00467-018-3900-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1100938663
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/29426974
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child, Preschool",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunologic Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Nephrotic Syndrome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rituximab",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kamei",
"givenName": "Koichi",
"id": "sg:person.01316365041.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316365041.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Ogura",
"givenName": "Masao",
"id": "sg:person.01174574062.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174574062.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Sato",
"givenName": "Mai",
"id": "sg:person.01060345462.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060345462.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Yokohama City University Graduate School pf Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Pediatrics, Yokohama City University Graduate School pf Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan"
],
"type": "Organization"
},
"familyName": "Ito",
"givenName": "Shuichi",
"id": "sg:person.012302533312.63",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.63906.3a",
"name": [
"Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Ishikura",
"givenName": "Kenji",
"id": "sg:person.01112735663.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112735663.13"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00467-009-1195-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028250994",
"https://doi.org/10.1007/s00467-009-1195-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10157-014-1030-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019458362",
"https://doi.org/10.1007/s10157-014-1030-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00467-012-2286-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009853115",
"https://doi.org/10.1007/s00467-012-2286-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.thj.6200133",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056649401",
"https://doi.org/10.1038/sj.thj.6200133"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-007-0329-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002510364",
"https://doi.org/10.1007/s00520-007-0329-5"
],
"type": "CreativeWork"
}
],
"datePublished": "2018-02-09",
"datePublishedReg": "2018-02-09",
"description": "BackgroundInfusion reaction (IR) is defined as an adverse event within 24\u00a0h after monoclonal antibody infusion. In non-Hodgkin lymphoma, IR incidence following rituximab treatment is high (77\u201380%), but there are no data in complicated nephrotic syndrome.MethodsRecords of rituximab infusions in patients with complicated nephrotic syndrome between February 2006 and December 2014 at the National Center for Child Health and Development were reviewed. Rituximab was administered at doses of 375\u00a0mg/m2. The severity of IR was evaluated using the Common Terminology Criteria for Adverse Events ver. 4.0.ResultsFor 309 rituximab infusions in 159 patients (male, 110; median age, 12\u00a0years), IR was observed in 165 infusions (53.4%). Respiratory symptoms were most common (66% of all events). Ninety-five percent of the IR was observed within 3\u00a0h after rituximab infusion initiation. Sixty-eight percent of the events were classified as grade 1 and others classified as grade 2. Only 18% required medical intervention. CD20 cell count in patients with IR was significantly higher than in patients without IR. Incidence of IR was similar in subsequent rituximab treatment after B-cell recovery. Patients who experienced IR at first rituximab treatment were more likely to experience recurrent IR with subsequent treatments compared to those not having IR at initial treatment (odds ratio 3.64; p\u2009<\u20090.001).ConclusionsIn patients with complicated nephrotic syndrome, respiratory symptoms were the major type of IR, mostly observed within 3\u00a0h of infusion. Incidence of IR was lower and its severity milder in patients with complicated nephrotic syndrome than those with lymphoma.",
"genre": "article",
"id": "sg:pub.10.1007/s00467-018-3900-z",
"inLanguage": "en",
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.9337961",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.9341874",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1097267",
"issn": [
"0931-041X",
"1432-198X"
],
"name": "Pediatric Nephrology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "6",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "33"
}
],
"keywords": [
"complicated nephrotic syndrome",
"rituximab treatment",
"nephrotic syndrome",
"rituximab infusion",
"respiratory symptoms",
"monoclonal antibody infusion",
"Adverse Events ver",
"Common Terminology Criteria",
"non-Hodgkin lymphoma",
"severity of IR",
"Terminology Criteria",
"ConclusionsIn patients",
"infusion reactions",
"adverse events",
"antibody infusion",
"initial treatment",
"infusion initiation",
"child health",
"patients",
"grade 2",
"cell count",
"infusion",
"syndrome",
"medical interventions",
"IR incidence",
"grade 1",
"incidence",
"cell recovery",
"subsequent treatment",
"treatment",
"lymphoma",
"symptoms",
"percent",
"MethodsRecords",
"rituximab",
"doses",
"severity",
"intervention",
"major types",
"National Center",
"health",
"count",
"milder",
"events",
"initiation",
"ver",
"m2",
"criteria",
"recovery",
"center",
"reaction",
"data",
"development",
"types",
"IR"
],
"name": "Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome",
"pagination": "1013-1018",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1100938663"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00467-018-3900-z"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"29426974"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00467-018-3900-z",
"https://app.dimensions.ai/details/publication/pub.1100938663"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:20",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_787.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00467-018-3900-z"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-3900-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-3900-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-3900-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-3900-z'
This table displays all metadata directly associated to this object as RDF triples.
204 TRIPLES
22 PREDICATES
94 URIs
81 LITERALS
15 BLANK NODES